Poliovirus replicons that express the gag or the envelope surface protein of simian immunodeficiency virus SIVsmm PBj 14

Virology

Volumn 219, Issue 1, 1996, Pages 140-149

  Anderson, Marie J ^a   Porter, Donna C ^a   Fultz, Patricia N ^a   Morrow, Casey D ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLIOVIRUS; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS; VACCINIA; VACCINIA VIRUS; ANIMALIA;

GAG PROTEIN; VIRUS ENVELOPE PROTEIN; VIRUS VACCINE; VIRUS VECTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; MOLECULAR CLONING; NONHUMAN; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; REPLICON; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0029891863     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.0231     Document Type: Article

References (43)

1. Alexander, L, Lu, H. H., Gromeier, M., and Wimmer, E. (1994). Strategies for inducing and evaluation of mucosal immunity. AIDS Res. Hum. Retroviruses (Suppl 2) 10, S57-S66.
2. Aliperti, G., and Schlesinger, M. J (1978). Evidence for an autoprotease activity of Sindbis virus capsid protein. Virology 90, 366-369.
3. Ansardi, D. C., Porter, D. C., and Morrow, C. D. (1991). Coinfection with recombinant vaccinia viruses expressing poliovirus P1 and P3 proteins results in polyprotein processing and formation of empty capsid structures. J Virol. 65, 2088-2092.
4. Ansardi, D. C., Porter, D. C., and Morrow, C. D. (1992). Myristylation of poliovirus capsid precursor P1 is required for assembly of subviral particles. J Virol. 66, 4556-4563.
5. Ansardi, D. C., Porter, D. C., and Morrow, C. D. (1993). Complementation of a poliovirus defective genome by a recombinant vaccinia virus which provides P1 capsid precursor in trans. J Virol. 67, 3684-3690.
6. Ansardi, D. C., Moldoveanu, Z, Porter, D. C., Walker, D. E., Conry, R M., LoBuglio, A. F., McPherson, S., and Morrow, C. D. (1994). Characterization of poliovirus replicons encoding carcinoembryonic antigens. Cancer Res. 54, 6359-6363.
7. Bryant, M., and Ratner, L. (1990). Myristoylation-dependent replication and assembly of human immunodeficiency virus 1. Proc. Natl. Acad. Sci. USA 87, 523-527.
8. Choi, W. S., Pal-Ghosh, R, and Morrow, C. D. (1991). Expression of human immunodeficiency virus type 1 HIV-1 gag, pol and env proteins from chimeric HIV-1-poliovirus minireplicons. J Virol. 65, 2875-2883.
9. Dewhurst, S., Embertson, J. E., Anderson, D. C., Mullins, J. L., and Fultz, P. N. (1990). Sequence analysis and acute pathogenicity of molecularly cloned SIVsmm-PBj14. Nature (London) 345, 636-640.
10. Doedens, J. R, and Kirkegaard, V. (1995). Inhibition of cellular protein secretion by poliovirus proteins 2B and 3A. EMBO J. 14, 894-907.
11. Doms, R W., Lamb, R, Rose, J. K., and Helenius, A. (1993). Folding and assembly of viral membrane proteins. Virology 193, 545-562.
12. Fultz, P. N. (1991). Replication of an acutely lethal simian immunodeficiency virus activates and induces proliferation of lymphocytes. J. Virol. 65, 4902-4904.
13. Fultz, P. N., McClure, H. M., Anderson, D. C., and Switzer, W. M. (1989). Identification and biologic characterization of an acutely lethal variant of simian immunodeficiency virus from sooty mangabeys (SIVsmm). AIDS Res. Hum. Retroviruses 51, 397-409.
14. Fultz, P. N., Schwiebert, R, and Stallworth, J (1995). AIDS-like disease following mucosal infection of pig-tailed macaques with SIVsmmPBj14. J. Med. Primatol., 24, 102-107.
15. Gallaher, W. R, Ball, J, Garry, R. F., Martin-Amedee, A. M., and Montel-aro, R. C. (1995). A general model for the surface glycoproteins of HIV and other retroviruses. AIDS Res. Hum. Retroviruses 11, 191-202.
16. Gething, M.-J, and Sambrook, J. (1992). Protein folding in the cell. Nature 355, 33-45.
17. Gheysen, D., Jacobs, E, de Foresta, F., Thiriart, C., Francotte, M., Thines, D., and De Wilde, M. D. (1989). Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells. Cell 59, 103-112.
18. Göttlinger, H. G., Sodroski, J. G., and Haseltine, W. A. (1989). Role of capsid precursor processing and myristylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 86, 5781-5785.
19. Harris, K. S., Hellen, C. U. T., and Wimmer, E. (1990). Proteolytic processing in the replication of picornaviruses. Semin. Virol. 1, 323-333.
20. Jore, J, Degues, B., Jackson, R. J, Pouwels, P. H., and Enger-Valk, B. E. (1988). Poliovirus protein 3CD is the active protease for processing of the precursor protein P1 in vitro. J Gen. Virol. 69, 1627-1636.
21. Karacostas, V., Nagashima, K., Gonda, M., and Moss, B. (1989). Human immunodeficiency virus-like particles produced by a vaccinia virus expression vector. Proc. Natl. Acad. Sci. USA 86, 8964-8967.
22. Kitamura, N., Semler, B. L., Rothberg, P. G., Larsen, G. R., Adler, C. J., Dorner, A. J., Emini, E. A., Hanecak, R, Lee, J. J., van der Werf, S., Anderson, C. W., and Wimmer, E. (1981). Primary structure, gene organization and polypeptide expression of poliovirus RNA. Nature (London) 291, 547-553.
23. Koch, F., and Koch, G. (1985). "The Molecular Biology of Poliovirus." Springer-Verlag, Vienna.
24. Liljestrom, P., and Garoff, H. (1991). Internally located cleavable signal sequences direct the formation of Semliki Forest virus membrane proteins from a polyprotein precursor. J. Virol. 65, 147-154.
25. Lu, H.-H., Alexander, L., and Wimmer, E. (1995). Construction and genetic analysis of dicistronic polioviruses containing open reading frames for epitopes of human immunodeficiency virus type 1 gp120. J Virol. 69, 4797-4806.
26. Melancon, P., and Garoff, H. (1987). Processing of the Semliki Forest virus structural polyprotein: Role of the capsid protease. J. Virol. 61, 1301-1309.
27. Moldoveanu, Z, Porter, D. C., Lu, A, McPherson, S., and Morrow, C. D. (1995). Immune responses induced by administration of encapsidated poliovirus replicons which express HIV-1 gag and envelope proteins. Vaccine 13, 1013-1022.
28. Morrow, C. D., Porter, D. C., Ansardi, D. C., Moldoveanu, Z, and Fultz, P. N. (1994). New approaches for mucosal vaccines for AIDS: Encap-sidation and serial passage of poliovirus replicons that express HIV-1 proteins on infection. AIDS Res. Hum. Retroviruses 10, S61-S66.
29. Novembre, F. J., Johnson, P. R., Lewis, M. G., Anderson, D. C., Klumpp, S., McClure, J. M., and Hirsch, V. M. (1993). Multiple viral determinants contribute to pathogenicity of acutely lethal simian immunode-ficiency virus SIVsmmPBj variant. J Virol. 67, 2466-2774.
30. Owens, R J, and Compans, R W. (1990). The human immunodeficiency virus type 1 envelope glycoprotein precursor acquires aberrant inter-molecular disulfide bonds that may prevent normal proteolytic pro-cessing. Virology 179, 827-833.
31. Park, J, and Morrow, C. D. (1992). The nonmyristylated PR1609a9″po1 polyprotein of human immunodeficiency virus type 1 interacts with Pr559agand is incorporated into virus-like particles. J Virol. 66, 6304-6313.
32. Park, J, and Morrow, C. D. (1993). Mutations in the protease gene of human immunodeficiency virus type-1 affect release and stability of virus particles. Virology 194, 843-850.
33. Porter, D. C., Ansardi, D. C., Choi, W. S., and Morrow, C. D. (1993). Encapsidation of genetically engineered poliovirus mini-replicons which express HIV-1 gag and pol proteins upon infection. J. Virol. 67, 3712-3719.
34. Porter, D. C., Ansardi, D. C., and Morrow, C. D. (1995). Encapsidation of poliovirus replicons encoding the complete human immunodeficiency virus type 1 gag gene using a complementation system which provides the P1 capsid protein in trans. J Virol. 69, 1548-1555.
35. Rey, M. A, Krust, B., Laurent, A. G., Montagnier, L., and Hovanessian, A. G. (1989). Characterization of human immunodeficiency virus type 2 envelope glycoproteins: Dimerization of the glycoprotein precursor during processing. J. Virol. 63, 647-658.
36. Rueckert, R., and Wimmer, E. (1984). Systematic nomenclature for picornavirus proteins. J. Virol. 50, 957-959.
37. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989). "Molecular Cloning: A Laboratory Manual," 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
38. Schwiebert, R, and Fultz, P. N. (1994). Immune activation and viral burden in acute disease induced by simian immunodeficiency virus SIVsmmPBj14: Correlation between in vitro and in vivo events. J Virol. 68, 5538-5547.
39. Semler, B. L., Dorner, A. J, and Wimmer, E. (1984). Production of infec-tious poliovirus from cloned cDNA is dramatically increased by SV40 transcription and replication signals. Nucleic Acids Res. 12, 5123-5141.
40. Steimer, K. S, Puma, J. P., Powers, M. D., George-Nascimento, C., Stephans, J. C., Levy, J. A., Sanchez-Pescador, R., Luciw, P. A., Barr, P. J, and Hallewell, R. A. (1986). Differential antibody responses of individuals infected with AID-associated retroviruses surveyed using viral core antigen p25gag expressed in bacteria. Virology 150, 283-290.
41. Toyoda, H., Nicklin, M. J H., Murray, M. G., Anderson, C. W., Dunn, J. J., Studier, F. W., and Wimmer, E. (1986). A second virus-encoded proteinase involved in proteolytic processing of poliovirus polyprotein. Cell 45, 761-770.
42. Ypma-Wong, M. F., and Semler, B. L. (1987). Processing determinants required for in vitro cleavage of the poliovirus P1 precursor to capsid proteins. J. Virol. 61, 3181-3189.
43. Ypma-Wong, M. F., Dewalt, P. G., Johnson, V. H., Lamb, J. G., and Semler, B. L. (1988). Protein 3CD is the major poliovirus proteinase responsible for cleavage of the P1 capsid precursor. Virology 166, 265-270.